CLOSE X
Bajaj Healthcare Ltd.
Issue Open Date 27-Apr-16  
Issue Closing Date 02-May-16  
Application Money 100  
Allotment Money  
Price Band () 170 -  
Minimum Bid Quantity. 800  
Issue Size (Shares) 1817600  
Market Lot 1  
Objective

The Objects of the Fresh Issue is to raise funds for:(a)Repayment of loans and(b)Funding expenditure for General Corporate Purposes.

Business Description

Our Company, Bajaj Healthcare Limited, is a pharmaceutical company with manufacturing and marketing capabilities in Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and Finished Dosage Forms (FDFs) catering to various therapeutic segments.Our Company began its operations...

Promoter's Holding
Total Share Capital   6309000  
Offered to Public   1817600  
Promoter's Holding (Pre-Issue)   93.47  
Promoter's Holding (Post-Issue)   67.26  
Address
Address :602-606
Bhoomi Velocity Infotech Park
Plot No. B-39
B-39/ A
B-39 A/1
Road No. 23
Wagle Industrial Estate
Thane (West)
City :Thane Dist, State :Maharashtra Pincode :401604 Phone :022 6617400 / 401 Email : bajajhealth@bajajhealth.com / investors@bajajhealth.com Website : www.bajajhealth.com
Registrar
Link Intime India Pvt Ltd.
Unit -1
Luthra Ind. Premises
Safed Pool
Andheri-Kurla Road
Andheri (E)
Mumbai
Listed at
BSE
Lead Manager
Aryaman Financial Services Ltd.
Promoters
Sanjankumar R Bajaj
BNK Securities Pvt. Ltd

CIN No.:U67120WB1995PTC071182 (ISO 90001:2015 & ISO 27001:2013 Certified Company)

Registered Office: Mayfair Tower, 2,Palm Avenue,Kolkata-700 019

Tel:+91-33-4602-2160/61/62/63 Email:contact@bnkcapital.com

BNK Securities Pvt Ltd. MEMBERS OF NSE, BSE AND MSEI SEBI Registration no: INZ000220037

SEBI Registration No: MB / INM000011641 (Category I Merchant Banker), Research Analyst. Reg no INH300003520

DEPOSITORY PARTICIPANT SEBI Registration No-In-DP-673-2022, CDSL DP ID - 12060500.

AMFI certified Mutual Fund Distributor Registration No: ARN–86507

For any grievances, investors can contact at: grievance@bnkstockline.com, Tel:+91-33-4602-2160/61/62/63

 ©  Copyrights 2022, BNK Capital Group All Rights Reserved

Designed & Developed - Accord Fintech Pvt. Ltd.